Research
-
Peabody researchers among top in country in new ‘Education Week’ rankings
"Education Week" has released the 2022 Edu-Scholar Public Influence Rankings, an annual list of education researchers who have demonstrated the greatest influence over educational policy and practice. Six researchers from Vanderbilt University’s Peabody College of education and human development are among the 200 who made the rankings. Read MoreJan 5, 2022
-
Vanderbilt University Coffee Equity Lab launches Coffee Equity Design Challenge
Vanderbilt's Coffee Equity Lab has launched the Coffee Equity Design Challenge, in which students and coffee professionals will team up to co-create meaningful innovations for a more equitable and sustainable coffee industry. Read MoreJan 5, 2022
-
Research: Classroom observation scores for Tennessee teachers vary by race and gender
New research by the Tennessee Education Research Alliance at Vanderbilt University’s Peabody College reveals that gaps among race and gender remain even when comparing similarly qualified teachers who perform the same according to other metrics, such as their value-added to student achievement. Read MoreJan 3, 2022
-
Study of fully vaccinated patients with cancer who had breakthrough COVID-19 shows 13% mortality rate
New research finds that fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death. Read MoreDec 24, 2021
-
Vanderbilt extends its longest ongoing drug discovery agreement with pharmaceutical company through 2023
Vanderbilt has extended its longest ongoing drug discovery agreement with Osaka, Japan-based Ono Pharmaceutical Co., Ltd., a research and development-oriented pharmaceutical company that is committed to creating innovative medicines in specific areas, through November 2023. Read MoreDec 21, 2021
-
Study finds pixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention, reduced bleeding complications
There is strong evidence that the medication apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stoke prevention in patients with atrial fibrillation (AF), with both reduced rates of severe bleeding complications as well as strokes, according to study published Dec. 21 in JAMA. Read MoreDec 21, 2021
-
“Atlas” of lung development may aid efforts to heal premature lungs
Researchers at Vanderbilt University Medical Center have constructed a single-cell “atlas” of lung development that tracks multiple cell types over time. Read MoreDec 20, 2021
-
Limited Submission Opportunity: 2023 Breast Cancer Alliance Exceptional Project Grant
Vanderbilt University may submit two letters of intent for the 2023 Breast Cancer Alliance Exceptional Project Grant. The mission of the Breast Cancer Alliance is to improve survival rates and quality of life for those impacted by breast cancer through better prevention, early detection, treatment and cure. Read MoreDec 19, 2021
-
Game theory points to new DNA data privacy solutions
by Paul Govern Information based biomedical discovery, in particular the push toward precision medicine, depends on open-ended analysis of de-identified data from patients and research participants on the largest possible scale. Sharing data while controlling the risk of data reidentification under privacy attack is vital to the enterprise. Zhiyu Wan Game theory indicates that only... Read MoreDec 17, 2021
-
Vanderbilt Poll 2021: Approval drops for TN’s elected leaders and second Trump run, but Dems and Republicans find unity on education, redistricting
Support for Gov. Bill Lee is down among Tennessee voters, fueled in part by his controversial stances on vaccine and mask requirements during the COVID-19 pandemic, according to the latest statewide Vanderbilt Poll. Read MoreDec 16, 2021
-
Study finds similar success rates with two devices for breathing tube placement
Two devices for placing a breathing tube during critical illness had similar success rates for intubation on the first attempt, according to a study published Dec. 8 in JAMA. Read MoreDec 15, 2021
-
Stephen Taylor receives NSF CAREER award to study gravitational waves from supermassive black holes
Stephen Taylor, assistant professor of physics and astronomy, has received a National Science Foundation Faculty Early Career Development Program award to further his efforts to probe ultra-low-frequency gravitational waves. Read MoreDec 14, 2021
-
Research Snapshot: Producing green fuel, and more rapid determination of the biological consequences of gene editing
Vanderbilt researchers examine how to rapidly characterize the biological impact of genetic editing on bacteria for energy production, drug discovery and more. Est. reading time: 2.5 mins. Read MoreDec 13, 2021
-
Limited Submission Opportunity: AAMC Herbert W. Nickens Faculty Fellowship
Vanderbilt (VU and VUMC) may nominate one assistant professor for the Association of American Medical Colleges Herbert W. Nickens Faculty Fellowship. Read MoreDec 13, 2021
-
Limited Submission Opportunity: 2022 Ono Pharma Breakthrough Science Initiative Awards
Vanderbilt may nominate two candidates to submit an LOI to the Ono Pharma Foundation’s Breakthrough Science Initiative Awards Program. Ono Pharmaceutical Co., Ltd. is a leading global health care company committed to delivering new, innovative pharmaceutical products to patients and championing the fight against disease and pain. Read MoreDec 13, 2021
-
Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization
The U.S. Food and Drug Administration granted emergency use authorization Dec. 8 to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination that protects against COVID-19, discovered last year at Vanderbilt University Medical Center. Read MoreDec 10, 2021
-
Alumni Innovators: Cybersecurity startup ARMS Cyber wins competitive awards from US Air Force, JPMorgan Chase and VetsinTech
Startup fostered at Vanderbilt earns accolades as it reimagines cybersecurity. Winning these awards earned the team $750,000 from the U.S. Air Force and $25,000 with mentorship from JPMorgan Chase leadership. Read MoreDec 10, 2021
-
Cell signaling targets in leukemia
Vanderbilt researchers identified a critical role for IL-1beta signaling in leukemia cells with a certain mutation, suggesting this pathway may be a good target for novel treatments. Read MoreDec 9, 2021
-
Prostate cancer treatment regret
Vanderbilt researchers suggest that to reduce treatment-related regret for men with localized prostate cancer, treatment preparation should focus on shared decision-making and aligning patient expectations with treatment toxicity. Read MoreDec 9, 2021
-
International study supports dupilumab for treatment of moderate-to-severe asthma in children
In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11 with moderate-to-severe asthma, offering a new option to these patients. Read MoreDec 8, 2021